Cabaletta Bio raises $128.2 million from common stock warrant exercises

Cabaletta Bio reported exercises of 53,090,190 common stock warrants issued in its June 2025 underwritten public offering.

• The warrants carried a $2.50 exercise price per share and were set to expire on Sept. 12, 2026.
• 5,275,100 warrants were exercised through June 30, 2026, generating about $13.2 million in gross proceeds.
• 46,011,900 warrants were exercised from July 1, 2026 through expiration, generating about $115 million in gross proceeds.
• Aggregate gross proceeds from warrant exercises totaled about $128.2 million from issuance through expiration.